Skip to main content

Table 1 Anthropometric, hemodynamic, and biochemical characteristics of the study population according to glucose tolerance status

From: Mean platelet volume (MPV) as new marker of diabetic macrovascular complications in patients with different glucose homeostasis

Variables

All

(n = 400)

NGT

(n = 179)

IFG/IGT

(n = 137)

T2DM (ND)

(n = 84)

Pa

Gender, m/f

Age, yrs

BMI, Kg/m2

SBP, mmHg

DBP, mmHg

Smoking habits

FPG, mg/dl

2-h glucose, mg/dl

FPI, µU/ml

2-h insulin, µU/ml

Matsuda index

Hs-CRP, mg/L

MPV, fl.

PLT µU/ml

TG, mg/dl

HDL, mg/dl

LDL, mg/dl

HbA1c mmol/mol

Tyg score

e-GFR, ml/min/1.73m2

251/149

60.1 ± 11.9

32.1 ± 10.4

138.0 ± 7.0

78.9 ± 8.2

138/262

98.5 ± 13.3

156.0 ± 50.5

15.4 ± 6.2

111.2 ± 63.3

52.4 ± 30.5

3.3 ± 2.4

8.7 ± 1.1

212.1 ± 65

136.3 ± 61.1

48.2 ± 11.8

109.4 ± 39.0

6.1 ± 0.8

8.7 ± 0.4

96.1 ± 21.5

108/71

59.2 ± 10.7

33.3 ± 14.1

137.3 ± 7.52

78.8 ± 10.2

64/115

89.2 ± 8.1

116.3 ± 19.6

11.9 ± 4.9

79.6 ± 37.2

71.8 ± 35.2

2.7 ± 1.9

8.0 ± 0.5

202.3 ± 53.3

129.0 ± 49.4

49.8 ± 11.3

112.4 ± 38.1

5.9 ± 0.6

8.6 ± 0.4

104.0 ± 20.9

87/50

60.9 ± 12.9

31.8 ± 6.2

138.3 ± 6.4

78 ± 9.4

46/91

102.2 ± 9.3

163.5 ± 29

17.5 ± 5.8

135 ± 68.2

37.9 ± 10.3

3.6 ± 2.9

8.7 ± 0.6

207.7 ± 55.6

133.0 ± 65.5

46.8 ± 11

104.9 ± 38.9

6.2 ± 1.0

8.7 ± 0.4

91.0 ± 21.7

56/28

60.9 ± 12.5

30.3 ± 4.8

139.1 ± 6.5

81.1 ± 9.1

28/56

112.5 ± 12.5

228.4 ± 35.9

19.6 ± 5.4

139.5 ± 69

34.8 ± 12.9

3.8 ± 2.1

10.2 ± 1.0

233.7 ± 59

157.3 ± 71.3

47.1 ± 13.7

111.7 ± 40.5

6.4 ± 0.7

9.0 ± 0.5

87.8 ± 16.6

0.597

0.436

0.08

0.116

0.167

0.928

< 0.0001*

< 0.0001$

< 0.0001#

< 0.0001º

< 0.0001

< 0.0001

< 0.0001

0.003@

0.001

0.054

0.209

< 0.0001

< 0.0001§

< 0.0001

  1. NGT = Normal Glucose Tolerance; IGT = Impaired Glucose Tolerance; IFG = Impaired fasting glucose T2DM = Type 2 Diabetes Mellitus; BMI = Body Mass Index; SBP = Systolic Blood Pressure; DBP = Diastolic Blood Pressure; FPG = Fasting Plasma Glucose; FPI = Fasting Plasma Insulin; TG = Triglycerides; HDL = high density lipoprotein; LDL = low density lipoprotein; MPV = Mean Platelets Volume; PLT = Platelets; hs-CRP = high-sensitivity C-reactive protein; e-GFR = estimated glomerular filtration rate; HbA1c = Glycated haemoglobin. Data are mean ± SD. a = Overall difference among groups (ANOVA)
  2. Bonferroni post-hoc analysis:
  3. * NGT vs. IGT/IFG p < 0.0001, NGT vs. DM2 p < 0.0001, IGT/IFG vs. DM2 p < 0.0001
  4. $ NGT vs. IGT/IFG p < 0.0001, NGT vs. DM2 p < 0.0001, IGT/IFG vs. DM2 p < 0.0001
  5. # NGT vs. IGT/IFG p < 0.0001, NGT vs. DM2 p < 0.0001, IGT/IFG vs. DM2 p = 0.016
  6. º NGT vs. IGT/IFG p < 0.0001, NGT vs. DM2 p < 0.0001
  7. ∆ NGT vs. IGT/IFG p < 0.0001, NGT vs. DM2 p < 0.0001
  8. @ NGT vs. IGT/IFG p < 0.0001, NGT vs. DM2 p < 0.0001
  9. • NGT vs. IGT/IFG p < 0.0001, NGT vs. DM2 p < 0.0001, IGT/IFG vs. DM2 p < 0.0001
  10. ∑ NGT vs. DM2 p < 0.0001
  11. † NGT vs. IGT/IFG p < 0.0001, NGT vs. DM2 p < 0.0001
  12. € NGT vs. IGT/IFG p = 0.016, NGT vs. DM2 p < 0.0001
  13. § NGT vs. IGT/IFG (p = 0.007), NGT vs. T2DM (p < 0.0001), IGT/IFG vs. T2DM (p < 0.0001)